Down 17.7% in 4 Weeks, Here's Why Genpact (G) Looks Ripe for a Turnaround — Positive

G   Zacks Investment Research — February 04, 2026

Genpact (G) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

image for news Down 17.7% in 4 Weeks, Here's Why Genpact (G) Looks Ripe for a Turnaround

S&P Global (SPGI) Loses 13.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner — Negative

SPGI   Zacks Investment Research — February 04, 2026

S&P Global (SPGI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

image for news S&P Global (SPGI) Loses 13.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for J&J Snack Foods (JJSF) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

image for news J&J Snack Foods (JJSF) Loses 11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Down 17.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Autodesk (ADSK) — Positive

ADSK   Zacks Investment Research — February 04, 2026

The heavy selling pressure might have exhausted for Autodesk (ADSK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

image for news Down 17.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Autodesk (ADSK)

Anthropic released plugins for its Claude Cowork AI agent the company claims can automate dozens of tasks, including plugins for customer service, product management, marketing, legal and data analysis, among others. Anthropic said the tools can generate financial statements, research sales prospects, prep for sales calls, draft customer support responses and assess non-disclosure agreements, as well as review contracts, legal briefings and build financial models.

image for news Global Software Stock Selloff—Oracle, Adobe, More—Fueled By Anthropic's New AI Tools

CAE: Trump Threats Hurt The Stock, But I Remain Bullish — Neutral

CAE   Seeking Alpha — February 04, 2026

CAE offers a compelling re-entry point after a 10% pullback, with 23% upside to 2027 price target. Recent share weakness is driven by US-Canada friction over aircraft certification, not by fundamental deterioration in CAE's outlook. CAE's margin profile and leverage are set to improve as legacy defense contracts are replaced by higher-margin opportunities.

image for news CAE: Trump Threats Hurt The Stock, But I Remain Bullish

Robinhood Q4 2025 Preview: Strong Momentum Ushering In A Key Quarterly Report — Neutral

HOOD   Seeking Alpha — February 04, 2026

Robinhood Markets, Inc. is rated a buy, driven by strong financial performance and sustained user engagement. HOOD has posted over 10 consecutive quarters of double-digit revenue growth, with Q3 2025 net income up 270% YoY and EPS up 259%. Despite premium valuation (P/E 41.61x), HOOD's 304% trailing EPS growth justifies its multiple, though high volatility and expense guidance pose risks.

image for news Robinhood Q4 2025 Preview: Strong Momentum Ushering In A Key Quarterly Report

GSK beat the numbers, but the real story was the guidance — Positive

GSK   Proactive Investors — February 04, 2026

A clean fourth-quarter beat pushed GSK ahead of its own medium-term targets. Yet management chose to set a deliberately modest bar for 2026, leaving investors to decide whether this is prudence or opportunity.

image for news GSK beat the numbers, but the real story was the guidance

Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook — Negative

NVO   Zacks Investment Research — February 04, 2026

Novo Nordisk slides 15% on a cautious 2026 sales outlook, but buybacks, leadership moves and Wegovy expansion put its ETFs in focus.

image for news Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook

4 Silver Mining Stocks to Buy to Benefit From Solid Industry Trends — Positive

ASM  BVN  FNLPF  HL   Zacks Investment Research — February 04, 2026

Rising silver prices and strong demand brighten the Zacks Mining - Silver outlook, making FNLPF, HL, BVN and ASM solid portfolio picks.

image for news 4 Silver Mining Stocks to Buy to Benefit From Solid Industry Trends

Brokers Suggest Investing in Disney (DIS): Read This Before Placing a Bet — Negative

DIS   Zacks Investment Research — February 04, 2026

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Brokers Suggest Investing in Disney (DIS): Read This Before Placing a Bet

Air Products and Chemicals (APD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, APD broke through the 200-day moving average, which suggests a long-term bullish trend.

image for news Air Products and Chemicals (APD) Crossed Above the 200-Day Moving Average: What That Means for Investors

Lam Research (LRCX) Boasts Earnings & Price Momentum: Should You Buy? — Positive

LRCX   Zacks Investment Research — February 04, 2026

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

image for news Lam Research (LRCX) Boasts Earnings & Price Momentum: Should You Buy?

Techne (TECH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Neutral

TECH   Zacks Investment Research — February 04, 2026

While the top- and bottom-line numbers for Techne (TECH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

image for news Techne (TECH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Is It Worth Investing in AutoZone (AZO) Based on Wall Street's Bullish Views? — Positive

AZO   Zacks Investment Research — February 04, 2026

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Is It Worth Investing in AutoZone (AZO) Based on Wall Street's Bullish Views?

Performance Food (PFGC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive

PFGC   Zacks Investment Research — February 04, 2026

Although the revenue and EPS for Performance Food (PFGC) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Performance Food (PFGC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Is Citigroup (C) a Buy as Wall Street Analysts Look Optimistic? — Positive

C   Zacks Investment Research — February 04, 2026

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Is Citigroup (C) a Buy as Wall Street Analysts Look Optimistic?

Compared to Estimates, Idex (IEX) Q4 Earnings: A Look at Key Metrics — Positive

IEX   Zacks Investment Research — February 04, 2026

Although the revenue and EPS for Idex (IEX) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Compared to Estimates, Idex (IEX) Q4 Earnings: A Look at Key Metrics

Brokers Suggest Investing in Seanergy Maritime Holdings (SHIP): Read This Before Placing a Bet — Negative

SHIP   Zacks Investment Research — February 04, 2026

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Brokers Suggest Investing in Seanergy Maritime Holdings (SHIP): Read This Before Placing a Bet

Timken (TKR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive

TKR   Zacks Investment Research — February 04, 2026

Although the revenue and EPS for Timken (TKR) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Timken (TKR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates